Study Name: Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir
18 locations found
- GSK Investigational Site
Location: Boston, Massachusetts 02115
- GSK Investigational Site
Location: Norwalk, Connecticut 06850
- GSK Investigational Site
Location: New York, New York 10011
- GSK Investigational Site
Location: Bronx, New York 10467
- GSK Investigational Site
Location: Buffalo, New York 14215
- GSK Investigational Site
Location: Philadelphia, Pennsylvania 19140
- GSK Investigational Site
Location: Washington, District of Columbia 20007
- GSK Investigational Site
Location: Washington, District of Columbia 20009
- GSK Investigational Site
Location: Annandale, Virginia 22003
- GSK Investigational Site
Location: Durham, North Carolina 27710
- GSK Investigational Site
Location: Savannah, Georgia 31401
- GSK Investigational Site
Location: Orlando, Florida 32803
- GSK Investigational Site
Location: Fort Lauderdale, Florida 33316
- GSK Investigational Site
Location: Fort Pierce, Florida 34982
- GSK Investigational Site
Location: Dallas, Texas 75246
- GSK Investigational Site
Location: Los Angeles, California 90069
- GSK Investigational Site
Location: Bakersfield, California 93301
- GSK Investigational Site
Location: Beverly Hills, California 90211
|